SPDR S&P Pharmaceuticals ETF (XPH) Performance
XPH total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +12.3% since Dec 31, 2025
- 1 year
- +29.7% total return
- 5 years
- +6.8% a year
- 10 years
- +5.0% a year
- Since first price
- +8.8% a year since 2006
XPH trailing returns vs SPY, QQQ, AGG
| Period | XPH total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −5.3% | −5.3% | −1.0% | −5.0% | +0.9% |
| 3 months | −8.4% | −8.5% | +3.2% | +1.9% | −0.4% |
| 6 months | +9.8% | +9.6% | +7.8% | +8.4% | −1.5% |
| YTD | +12.3% | +11.9% | +12.3% | +15.1% | −1.0% |
| 1 year | +29.7% | +29.1% | +14.4% | +15.9% | −1.1% |
| 3 years | +79.1%+21.4%/yr | +73.3% | +87.4%+23.3%/yr | +101.4%+26.3%/yr | +16.6%+5.2%/yr |
| 5 years | +39.0%+6.8%/yr | +30.7% | +79.3%+12.4%/yr | +94.0%+14.2%/yr | −0.8%−0.2%/yr |
| 10 years | +63.0%+5.0%/yr | +48.2% | +315.9%+15.3%/yr | +538.9%+20.4%/yr | +14.0%+1.3%/yr |
| 15 years | +242.5%+8.6%/yr | +162.5% | +696.0%+14.8%/yr | +1,299.3%+19.2%/yr | +32.2%+1.9%/yr |
| 20 years | +393.5%+8.3%/yr | +254.9% | +696.9%+10.9%/yr | +1,839.9%+16.0%/yr | +79.6%+3.0%/yr |
| Since inceptionJun 22, 2006 | +460.1%+8.8%/yr | +301.8% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: XPH vs SPY
From Jun 22, 2006: XPH grew to $56,005, SPY to $88,403.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
XPH returns by calendar year
13 of 19 full years positive. Best 2013 (+60.8%), worst 2016 (−23.2%). 2026 is year to date.
XPH annual returns table
| Year | XPH | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +12.3% | −16.4% | +12.3% | +15.1% | −1.0% |
| 2025 | +31.6% | −19.7% | +17.7% | +20.8% | +7.2% |
| 2024 | +4.9% | −13.7% | +24.9% | +25.6% | +1.3% |
| 2023 | +3.0% | −20.0% | +26.2% | +54.9% | +5.7% |
| 2022 | −9.8% | −17.9% | −18.2% | −32.6% | −13.0% |
| 2021 | −10.5% | −21.6% | +28.7% | +27.4% | −1.8% |
| 2020 | +14.7% | −34.0% | +18.3% | +48.6% | +7.5% |
| 2019 | +25.6% | −19.7% | +31.2% | +39.0% | +8.5% |
| 2018 | −15.3% | −30.1% | −4.6% | −0.1% | +0.1% |
| 2017 | +12.0% | −9.6% | +21.7% | +32.7% | +3.6% |
| 2016 | −23.2% | −26.7% | +12.0% | +7.1% | +2.4% |
| 2015 | +1.7% | −33.1% | +1.2% | +9.4% | +0.5% |
| 2014 | +29.5% | −14.5% | +13.5% | +19.2% | +6.0% |
| 2013 | +60.8% | −4.4% | +32.3% | +36.6% | −2.0% |
| 2012 | +10.9% | −13.2% | +16.0% | +18.1% | +3.8% |
| 2011 | +12.7% | −17.6% | +1.9% | +3.4% | +7.7% |
| 2010 | +22.5% | −10.9% | +15.1% | +19.9% | +6.4% |
| 2009 | +27.7% | −22.9% | +26.4% | +54.7% | +3.0% |
| 2008 | −9.0% | −30.8% | −36.8% | −41.7% | +7.9% |
| 2007 | −1.0% | −13.7% | +5.1% | +19.0% | +6.6% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
XPH largest drawdowns
Now 15.3% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jul 22, 2015 | −48.0% | Mar 23, 2020 | Dec 22, 2025 | 4.7 years | 10.4 years |
| May 9, 2007 | −35.3% | Mar 5, 2009 | Oct 14, 2009 | 1.8 years | 2.4 years |
| Jul 7, 2011 | −17.6% | Aug 8, 2011 | Jan 9, 2012 | 32 days | 6 months |
| Aug 19, 2026 | −16.4% | Oct 16, 2026 | not yet | 58 days | 2 months so far |
| Mar 5, 2014 | −14.5% | Apr 14, 2014 | Jun 20, 2014 | 40 days | 4 months |
| Sep 18, 2012 | −13.2% | Nov 15, 2012 | Feb 19, 2013 | 58 days | 5 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
XPH risk statistics
| Statistic | 3 years | 5 years | 10 years | Since 2006 |
|---|---|---|---|---|
| Annualized return | +19.1% | +7.8% | +4.9% | +8.9% |
| Volatility (annualized) | 20.4% | 18.9% | 20.0% | 19.4% |
| Sharpe ratio | 0.75 | 0.30 | 0.23 | 0.47 |
| Sortino ratio | 1.35 | 0.48 | 0.34 | 0.70 |
| Best month | +15.2% | +15.2% | +16.4% | +16.4% |
| Worst month | −9.9% | −9.9% | −15.9% | −18.9% |
| Best 12 months | +66.3% | +66.3% | +66.3% | +66.3% |
| Worst 12 months | −3.4% | −14.2% | −28.5% | −30.2% |
| Positive months | 64% | 58% | 54% | 59% |
| Beta vs S&P 500 | 0.58 | 0.61 | 0.81 | — |
| Correlation with S&P 500 | 0.35 | 0.50 | 0.62 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
XPH rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 233 | −30.2% | +8.2% | +66.3% | 67% |
| 3-year (a year) | 209 | −10.0% | +5.4% | +35.5% | 76% |
| 5-year (a year) | 185 | −8.5% | +6.4% | +33.3% | 83% |
| 10-year (a year) | 125 | −3.0% | +9.1% | +15.4% | 90% |
Every holding period starting at a month-end since 2006. Returns for 3 years and longer are annualized.
XPH performance overview
SPDR S&P Pharmaceuticals ETF (XPH) returned +29.7% over the past year and +5.0% a year over ten years, with distributions reinvested. Since its first recorded price in 2006 it has returned +8.8% a year, turning $10,000 into about $56,005. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −48.0%, from Jul 22, 2015 to Mar 23, 2020, and it took 5.7 years to get back to the old high. XPH finished 13 of its 19 full calendar years with a gain; the best year was 2013 (+60.8%) and the worst 2016 (−23.2%). Volatility has been 19.4% a year.
Related: XPH chart, XPH holdings, XPH dividends. See the XPH overview for the latest quote and fund facts.
XPH performance FAQ
What is the XPH return over the past year?
XPH returned +29.7% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 29.1%.
What is the average annual return of XPH?
XPH has returned +6.8% a year over 5 years, +5.0% a year over 10 years, +8.8% a year since June 22, 2006 (total return, distributions reinvested).
How much would $10,000 invested in XPH be worth?
$10,000 invested in XPH at its first recorded close on June 22, 2006 would be worth about $56,005 on October 23, 2026 with distributions reinvested.
What was the worst year for XPH?
The worst calendar year was 2016, with a total return of −23.2%. The best was 2013 at +60.8%.
What is the biggest drawdown of XPH?
The largest peak-to-trough decline was −48.0% between July 22, 2015 and March 23, 2020. It recovered to the old high on December 22, 2025, 5.7 years after the bottom.
How volatile is XPH?
Over the past 3 years XPH had an annualized volatility of 20.4% and a Sharpe ratio of 0.75 (excess return over 1–3 month T-bills per unit of risk).